Karis Bio
Seoul, Seoul-t'ukpyolsi, South Korea
About Karis Bio
Karis Bio develops innovative cell therapy for cardiovascular disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $7.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2021)
- Website: karisbio.com
- Phone: +82 2-363-0890
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/karis-bio-2504420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.